117 related articles for article (PubMed ID: 19576172)
1. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
[TBL] [Abstract][Full Text] [Related]
2. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
Wu S; Murai S; Kataoka K; Miyagishi M
Biochem Biophys Res Commun; 2008 Jan; 365(1):75-81. PubMed ID: 17980704
[TBL] [Abstract][Full Text] [Related]
3. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
4. Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.
Harr MW; Graves TG; Crawford EL; Warner KA; Reed CA; Willey JC
Mol Cancer; 2005 Jul; 4():23. PubMed ID: 16014176
[TBL] [Abstract][Full Text] [Related]
5. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
6. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
[TBL] [Abstract][Full Text] [Related]
7. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
Yang SZ; Lin FT; Lin WC
EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
[TBL] [Abstract][Full Text] [Related]
8. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
[TBL] [Abstract][Full Text] [Related]
9. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
Aoki I; Higuchi M; Gotoh Y
Oncogene; 2013 Aug; 32(34):3954-64. PubMed ID: 23001041
[TBL] [Abstract][Full Text] [Related]
10. Acetylation status of E2F-1 has an important role in the regulation of E2F-1-mediated transactivation of tumor suppressor p73.
Ozaki T; Okoshi R; Sang M; Kubo N; Nakagawara A
Biochem Biophys Res Commun; 2009 Aug; 386(1):207-11. PubMed ID: 19523927
[TBL] [Abstract][Full Text] [Related]
11. Cooperative regulation of p73 promoter by Yin Yang 1 and E2F1.
Wu S; Murai S; Kataoka K; Miyagishi M
Nucleic Acids Symp Ser (Oxf); 2007; (51):347-8. PubMed ID: 18029729
[TBL] [Abstract][Full Text] [Related]
12. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
13. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
Zhang L; Nie L; Maki CG
Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.
Kikuchi H; Ozaki T; Furuya K; Hanamoto T; Nakanishi M; Yamamoto H; Yoshida K; Todo S; Nakagawara A
Oncogene; 2006 Dec; 25(58):7608-17. PubMed ID: 16953234
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.
Kasim V; Huang C; Zhang J; Jia H; Wang Y; Yang L; Miyagishi M; Wu S
Biochem Biophys Res Commun; 2014 Jul; 449(3):319-26. PubMed ID: 24845566
[TBL] [Abstract][Full Text] [Related]
16. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
[TBL] [Abstract][Full Text] [Related]
17. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
18. Regulation of telomerase activity by the p53 family member p73.
Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
[TBL] [Abstract][Full Text] [Related]
19. Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation.
Sang M; Ando K; Okoshi R; Koida N; Li Y; Zhu Y; Shimozato O; Geng C; Shan B; Nakagawara A; Ozaki T
Genes Cells; 2009 Jul; 14(7):775-88. PubMed ID: 19490146
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
Ozono E; Komori H; Iwanaga R; Tanaka T; Sakae T; Kitamura H; Yamaoka S; Ohtani K
Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
